SMS Pharmaceuticals Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹120.9
- Today's High:
- ₹127.05
- Open Price:
- ₹125.5
- 52W Low:
- ₹54.5
- 52W High:
- ₹139.75
- Prev. Close:
- ₹127.15
- Volume:
- 6060
Company Statistics
- Market Cap.:
- ₹11.06 billion
- Book Value:
- 54.064
- Revenue TTM:
- ₹5.93 billion
- Operating Margin TTM:
- 8.37%
- Gross Profit TTM:
- ₹1.89 billion
- Profit Margin:
- 2.54%
- Return on Assets TTM:
- 1.61%
- Return on Equity TTM:
- -1.52%
Company Profile
SMS Pharmaceuticals Limited had its IPO on under the ticker symbol SMSPHARMA.
The company operates in the Healthcare sector and Drug Manufacturers-General industry. SMS Pharmaceuticals Limited has a staff strength of 0 employees.
Stock update
Shares of SMS Pharmaceuticals Limited opened at ₹125.5 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹120.9 - ₹127.05, and closed at ₹123.15.
This is a -3.15% slip from the previous day's closing price.
A total volume of 6,060 shares were traded at the close of the day’s session.
In the last one week, shares of SMS Pharmaceuticals Limited have slipped by -3.83%.
SMS Pharmaceuticals Limited's Key Ratios
SMS Pharmaceuticals Limited has a market cap of ₹11.06 billion, indicating a price to book ratio of 1.5603 and a price to sales ratio of 1.7592.
In the last 12-months SMS Pharmaceuticals Limited’s revenue was ₹5.93 billion with a gross profit of ₹1.89 billion and an EBITDA of ₹819.87 million. The EBITDA ratio measures SMS Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, SMS Pharmaceuticals Limited’s operating margin was 8.37% while its return on assets stood at 1.61% with a return of equity of -1.52%.
In Q2, SMS Pharmaceuticals Limited’s quarterly earnings growth was a negative -3.7% while revenue growth was a positive 110.2%.
SMS Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 73.427
- PEG
Its diluted EPS in the last 12-months stands at ₹1.78 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SMS Pharmaceuticals Limited’s profitability.
SMS Pharmaceuticals Limited stock is trading at a EV to sales ratio of 2.3931 and a EV to EBITDA ratio of 24.5516. Its price to sales ratio in the trailing 12-months stood at 1.7592.
SMS Pharmaceuticals Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.23% and a payout ratio of 22.89%.
Balance sheet and cash flow metrics
- Total Assets
- ₹8.80 billion
- Total Liabilities
- ₹2.55 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 22.89%
SMS Pharmaceuticals Limited ended 2025 with ₹8.80 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹8.80 billion while shareholder equity stood at ₹4.61 billion.
SMS Pharmaceuticals Limited ended 2025 with ₹0 in deferred long-term liabilities, ₹2.55 billion in other current liabilities, 84652000.00 in common stock, ₹4.52 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹73.78 million and cash and short-term investments were ₹139.79 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.21 billion.
SMS Pharmaceuticals Limited’s total current assets stands at ₹4.11 billion while long-term investments were ₹0 and short-term investments were ₹66.01 million. Its net receivables were ₹1.48 billion compared to accounts payable of ₹1.13 billion and inventory worth ₹2.23 billion.
In 2025, SMS Pharmaceuticals Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, SMS Pharmaceuticals Limited paid ₹0.23 in dividends in 2025.
Other key metrics
- Current Trading Price
- ₹123.15
- 52-Week High
- ₹139.75
- 52-Week Low
- ₹54.5
- Analyst Target Price
- ₹
SMS Pharmaceuticals Limited stock is currently trading at ₹123.15 per share. It touched a 52-week high of ₹139.75 and a 52-week low of ₹139.75. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹117.33 and 200-day moving average was ₹88.74 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7200.1% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About SMS Pharmaceuticals Limited
Similar Industry Stocks (Drug Manufacturers-General)
Most Active
Top Gainers
Top Losers
About
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.